CFO’s Quiet Option Play Signals Alterity Therapeutics’ Hopeful Pivot Amid Low‑Priced Stock Volatility
Alterity Therapeutics CFO’s new option purchase signals a quiet shift in management outlook, hinting at potential upside as the company nears clinical milestones.
3 minutes to read